Search This Blog

Tuesday, May 6, 2025

Supreme Court Lets Trump Admin Ban Trans Troops As Hegseth Says "We're Done With That Sh*t"

 The Supreme Court on Tuesday granted a stay allowing the Trump administration to ban troops who identify as transgender while litigation plays out in a lower court.

A majority of justices agreed to enter a stay of a preliminary injunction issued by a US district judge in March, pending the disposition of an appeal.

Opposing the stay, of course, were Justices Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson.

The decision is a big loss for seven transgender men, led by lead plaintiff Emily Schilling, a Navy commander, who sued to block the Trump admin from busting her balls.

"Today’s Supreme Court ruling is a devastating blow to transgender service members who have demonstrated their capabilities and commitment to our nation’s defense," said Lambda Legal and Human Rights Campaign Foundation - two groups representing the plaintiffs, said in a joint statement, adding that the policy "has nothing to do with military readiness and everything to do with prejudice."

In a separate case, a judge in Washington, D.C., also blocked the policy nationwide, but the U.S. Court of Appeals for the District of Columbia Circuit put that ruling on hold temporarily while it heard arguments on whether to block it more permanently. The court has yet to rule.

The policy, announced in February, is much more comprehensive ban than a similar proposal implemented during the first Trump term. It "generally disqualifies from military service individuals who have gender dysphoria or have undergone medical interventions for gender dysphoria," Solicitor General D. John Sauer said in court papers. -NBC News

Meanwhile, Defense Secretary Pete Hegseth said in a fiery speech on Tuesday that the US military will return to a warrior ethos.

"We are leaving wokeness and weakness behind. No more pronouns, no more climate change obsession, no more emergency vaccine mandates. No more dudes in dresses. We’re done with that shit," he said, adding "We’re focused on lethality, meritocracy, accountability, standards and readiness."

 https://www.zerohedge.com/military/supreme-court-lets-trump-admin-ban-trans-troops-hegseth-says-were-done-sht

Oklo, Nuclear Names Surge After Report White House “Accelerating” Nuclear With Exec Orders

 Nuclear stocks jumped mid day Tuesday after Axios reported that The White House is poised to issue executive orders aimed at accelerating the deployment of nuclear reactors across the United States.

One of our favorite names in the space, Oklo, spiked to new highs heading into the closing 30 minutes of the cash session on strong volume:

The White House actions are expected to leverage the Departments of Defense and Energy to expedite reactor deployment, potentially circumventing delays from the Nuclear Regulatory Commission (NRC).

This initiative aligns with the administration’s strategy to meet the surging energy demands driven by sectors like artificial intelligence and advanced manufacturing.

Publicly traded companies positioned to benefit from this nuclear expansion include our favorite, Oklo, formerly backed by OpenAI CEO Sam Altman.

The company is among eight companies selected to provide microreactors for U.S. military bases, aiming to supply 100% of critical energy needs at these sites.

These developments are part of a broader trend toward revitalizing the U.S. nuclear energy sector.

The ADVANCE Act of 2024, signed into law in July, aims to streamline the licensing process for advanced nuclear technologies, reduce regulatory costs, and promote the development of next-generation reactors.

Additionally, in a rare show of bipartisan agreement, the Biden administration had formerly expressed intentions to triple the nation’s nuclear power capacity by 2050, recognizing nuclear energy’s role in achieving carbon-free electricity goals.

The anticipated executive actions reflect a concerted effort to modernize the U.S. energy infrastructure, with nuclear power playing a central role in ensuring energy security and meeting future demands.

As of early 2025, 411 nuclear reactors operated worldwide with a combined 371-gigawatt capacity. Amazon, investing over $1 billion in nuclear projects, is exploring small modular reactors, while Meta and Google are also considering the emerging technology.

We've been following the story since late 2023. We wrote back in early November that Mark Zuckerberg reportedly told Meta workers that plans to build an AI data center powered by nuclear energy were scrapped after rare bees were discovered on the proposed site.

But by December last year it looked like things could be back on track, according to reporting from Axios, who noted first that Meta is joining industry heavyweights like Amazon and Google in exploring nuclear energy as a zero-carbon solution.

And as we have continued to report, accelerating power demand growth from AI data centers has sparked a nuclear power revival in the US:

For those who missed it, in our note "The Next AI Trade" from April 2024, more than one year ago, we outlined various investment opportunities for powering up America, most of which have dramatically outperformed the market since then.

https://www.zerohedge.com/markets/oklo-other-nuclear-names-spike-after-report-white-house-accelerating-nuclear-executive

US, Iran To Hold 4th Round Of Talks As Trump Calls For "Total Dismantlement" Of Nuclear Program

 Bloomberg and other sources have cited Iran's Nournews to report the resumption of Iran-US nuclear talks set for Sunday (May 11), according to an unnamed officials.

This will be the fourth round of talks, scheduled to take place in Oman's capital Muscat, amid fears that nuclear dialogue between Iran and the Trump administration was stalling.

The timing and location are interesting, given that Oman is in southern Arabia, and not too far away there is a war on in the Red Sea region, and Israel has ramped up airstrikes on Yemen, targeting Houthi leadership and infrastructure. Israel on Tuesday targeted the country's civilian aviation hub - Sanaa international airport. This came after the Iran-backed Houthis launched a ballistic missile on Israel's Ben Gurion airport in Tel Aviv.

Both Israel and the US have put Iran on notice related to the Houthis, alleging that Houthi military decisions are ultimately made in Tehran, something which Iranian leaders have rejected.

President Trump meanwhile issued some fresh and provocative statements during a "Meet the Press" interview which aired Sunday.

He for the first time spelled out that negotiations with Iran are aimed at achieving "full dismantlement" of Tehran's nuclear program.

"Total dismantlement. Yes, that is all I would accept," Trump told show host Kristen Welker. Ever since Trump during his first administration pulled out of the JCPOA nuclear deal in April 2018, Iran has steadily increased its enriched uranium stockpiles.

The Islamic Republic has, however, consistently stressed it only seeks peaceful nuclear energy development for the needs of its large domestic populace.

"I want Iran to be really successful, really great, really fantasticThe only thing they can't have is a nuclear weapon. If they want to be successful, that's okay. I want them to be so successful," Trump continued in his remarks.

"I just don't want them to have a nuclear weapon because the world will be destroyed," he added. US ally Israel has long warned it could preemptively attack Iran nuclear sites if it believes the Iranians are on the cusp of building a nuclear weapon.

Secretary of State Marco Rubio has recently left a diplomatic opening regarding nuclear energy. "There's a pathway to a civil, peaceful nuclear program if they want one," he recently said on the "Honestly with Bari Weiss" podcast.

Hawks in the US administration and the powerful Israeli lobby have urged Trump to get tougher on Iran, and to greenlight preemptive Israeli action. The Israelis understand that to make any real dent in Iran's military and nuclear infrastructure, it would need American protection over Middle East skies.

So far, Trump has refused to sign on to starting a new major war in the Middle East, and he is holding out for achieving a fresh nuclear deal with Tehran - but there is a lot working against this - not least of which is the war in Yemen.

https://www.zerohedge.com/geopolitical/us-iran-hold-4th-round-talks-trump-calls-total-dismantlement-nuclear-program

Easy fix for the Newark Airport disaster nobody’s going to like

 The chaos at Newark Liberty International Airport could be solved with a simple fix — even though it would be a different kind of headache for flyers who want to use the New Jersey travel hub, aviation pros said Monday.

Officials need to slash daily flights at the beleaguered airport as soon as possible because the facility isn’t big enough to handle the high volume operating there, ex-Federal Aviation Administration Safety Team Kyle Bailey told The Post.

Still, he warned short-term flying pain won’t be alleviated with a runway closed until mid-June — and as the airport faces a severe shortage of air traffic controllers that has especially hit United Airlines the hardest.

Passengers check the departures board at United Airlines Terminal C at Newark Airport.Luiz C. Ribeiro for New York Post

“I don’t see a near-term immediate everything gets better (solution),” Bailey said. 

“They simply need to permanently reduce daily flights into the airport, permanently combined with using bigger planes.”

“So there is not a silver bullet,” he added.

Newark Airport, which served nearly 50 million flyers in 2024, has recently faced an avalanche of cancellations and delays that became more pronounced in the past week with the loss of multiple air traffic controllers.

United, which uses the airport as its primary East Coast hub, even announced Friday it was scrapping 35 round-trip flights each day “in order to protect customers.”

On Monday, the airline offered customers the chance to change their flight date or connection city without a tacked-on fee, citing the shortages at air traffic control and lousy weather, according to a message a flyer showed The Post.

United has been under fire for the delays and cancellations.REUTERS

At least five air traffic controllers who work the arriving and departing flights at Newark took up to 45 days of “trauma leave” recently, CNN reported Monday.

There were about 153 cancellations and 329 delays at the airport Monday, according to FlightAware data – though some of that could be attributed to rainy weather.

Bailey, a former pilot, noted that while Newark is a “true international airport,” the facility is only the size of a big domestic airport.

“I think when that airport was designed, it wasn’t meant to be handling this volume of flights,” he said.

Newark is around 2,000 acres, while John F. Kennedy International Airport in nearby Queens, New York, is more than double that size.

Another aviation pro, Capt. Ross “Rusty” Aimer, told The Post that Newark wasn’t constructed decades ago around the newer and bigger passenger aircraft.

The delays have caused misery for flyers.Christopher Sadowski

“The runway design wasn’t that good those days and wasn’t built to accommodate endless commercial jumbo jets flying in and out,” the retired United pilot and now CEO of Aero Consulting Experts explained.

He said using Newark is a “legitimate worry.”

“I would worry as a pilot because you need to increase your awareness 100% and when the system is not working properly it increases the danger,” Aimer said. 

“On the other hand, we have great, fantastic air traffic controllers. By the time you get to that level where you are in Newark or Kennedy or LA — you are at the top of your game and the best there is.”

Voicing Bailey’s sentiment, Aimer said a temporary Band-Aid would be to cut down on flights — though he warned that’s a “catch-22.”

“We are not even at summer holiday traffic yet, and we’re already beginning to see these problems,” he said.

“Government agencies need to start hiring and training as fast as possible,” Aimer added. “They need to raise salaries not only to attract talent, but because the job is extremely stressful.”

Bailey insisted that despite the chaos at Newark, safety isn’t an issue.

“It’s more of a major inconvenience issue,” the expert said. “You really can’t depend on traveling from there if you need to be from point A to B.”

https://nypost.com/2025/05/05/us-news/theres-an-easy-fix-for-the-newark-airport-disaster-and-nobodys-going-to-like-it/

Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal

 

The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral sclerosis, coming less than a year after the pharma licensed QurAlis’ antisense oligonucleotide to correct a specific protein alteration in ALS.

Eli Lilly inked a licensing agreement with Alchemab Therapeutics, gaining access to the U.K. biotech’s early-stage therapy for amyotrophic lateral sclerosis.

Financial details of the arrangement were slim, with the companies revealing Tuesday only that the total deal could be worth up to $415 million, including an undisclosed upfront payment as well as discovery, development and commercialization milestones. On top of this sum, Alchemab will also be entitled to royalties if the collaboration asset makes it to market.

It’s the second biotech that Lilly has teamed up with in the past year to develop novel therapies for ALS. Last June, the pharma company paid QurAlis $45 million upfront and pledged up to $577 million in milestones, plus tiered royalties, for the exclusive global license to QurAlis’ investigational therapy QRL-204, an antisense oligonucleotide that helps restore the function of a specific protein central to the pathology of ALS.

The drug at the heart of Tuesday’s announcement is ATLX-1282, an investigational antibody that targets a protein called UNC5C, which is implicated in a variety of neurodegenerative diseases. According to Tuesday’s announcement, ATLX-1282 has first-in-class potential and is ready for an investigational new drug (IND) application.

As with QRL-204, the partners will advance ATLX-1282 for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Alchemab will usher the molecule through early Phase I development, after which Lilly will take charge and assume responsibility over all further clinical studies, regulatory activities and commercialization.

Lilly and Alchemab first linked up in January, also to address ALS. That agreement, which involved undisclosed payments, focused on the use of Alchemab’s technology platform to identify and advance up to five novel therapies for the disease. Tuesday’s announcement “builds” on this prior arrangement, but is “separate” from the January deal, according to the companies’ press announcement.

Beyond ALS, Lilly has been on an aggressive dealmaking spree in recent months. In January, for instance, the pharma inked a pair of contracts: a $780 million licensing pact for Mediar Therapeutics’ idiopathic pulmonary fibrosis drug and a potential $2.5 billion agreement for Scorpion Therapeutics’ PI3Kα inhibitor, which the pharma will develop for breast cancer and other solid tumors.

Lilly again signed back-to-back deals in February, teaming up with South Korea’s OliX Pharmaceuticals and Australia’s AdvanCell for cardiometabolic and cancer treatments, respectively. Last month, the pharma licensed a proprietary AAV vector capsid from Sangamo Therapeutics for $18 million upfront, plus the promise of up to $1.4 billion in certain milestones.

https://www.biospace.com/deals/lilly-deepens-als-pipeline-with-415m-alchemab-licensing-deal

Viatris (VTRS) Withdraws European Marketing of Cancer Drug

 The European Commission has withdrawn Viatris' (VTRS) authorization to market arsenic trioxide in the European Union. This decision follows Viatris' strategic move to cease sales of the cancer treatment, a choice made for commercial considerations. Originally granted approval in 2020, the marketing rights were relinquished at the request of Mylan Ireland Limited, a subsidiary of Viatris.

https://www.gurufocus.com/news/2832649/viatris-vtrs-withdraws-european-marketing-of-cancer-drug

Tiziana: Clinical Trial Success: Nasal Spray Halts Multiple Sclerosis Progression

 

  • Tiziana Life Sciences announced positive results from a study on nasal foralumab for MS.
  • The study showed nasal foralumab is safe and effective in stabilizing MS progression.